Importantly, exposure to inflammatory cytokines, such as TNF and IL-6, and activation of NF-κB in muscle can decrease oxidative metabolism, induce atrophy, and prevent insulin-stimulated Akt phosphorylation, all of which are factors in the development of type 2 diabetes and metabolic syndrome. Here, AKT1 is linked to type 2 diabetes mellitus.